Prevention of preterm birth in modern obstetrics

Clinics in Perinatology

Volumn 41, Issue 4, 2014, Pages 773-785

  Markham, Kara B ^a   Klebanoff, Mark ^b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cerclage; Pessary; Preterm birth; Preterm birth prevention; Progestins

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; GESTAGEN; HYDROXYPROGESTERONE CAPROATE; MAGNESIUM SULFATE; NIFEDIPINE; NITRIC OXIDE DONOR; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; TERBUTALINE SULFATE; UTERUS SPASMOLYTIC AGENT; VASOPRESSIN RECEPTOR ANTAGONIST;

ARTICLE; BED REST; CERCLAGE APPLIER; CHLAMYDIASIS; CYSTITIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GROUP B STREPTOCOCCAL INFECTION; HOME MONITORING; HOME UTERINE ACTIVITY MONITOR; HUMAN; LIFESTYLE MODIFICATION; NEISSERIACEAE INFECTION; NEWBORN INTENSIVE CARE; PERINATAL MORTALITY; PREMATURE LABOR; PYELONEPHRITIS; TRICHOMONIASIS; UROGENITAL TRACT INFECTION; UTERINE CERVIX CERCLAGE; UTERINE CERVIX DILATATION; UTERUS CONTRACTION; VAGINA CANDIDIASIS; VAGINA PESSARY; VAGINITIS; FEMALE; PREGNANCY; PREMATURE BIRTH; SMOKING CESSATION;

BED REST; CERCLAGE, CERVICAL; FEMALE; HUMANS; PESSARIES; PREGNANCY; PREMATURE BIRTH; PROGESTINS; SMOKING CESSATION; TOCOLYTIC AGENTS;

EID: 84910149440     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2014.08.003     Document Type: Review

References (76)

1. Hamilton B.E., Martin J.A., Ventura S.J. Births: preliminary data for 2011. National vital statistics reports 2012, vol. 61. National Center for Health Statistics, Hyattsville (MD), no. 5.
2. Urquhart C., Currell R., Harlow F., et al. Home uterine monitoring for detecting preterm labour. Cochrane Database Syst Rev 2012, (5). CD006172.
3. Committee on Practice Bulletins-Obstetrics, The American College of Obstetricians and Gynecologists Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012, 120:964.
4. Neilson J.P., West H.M., Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2014, (2). CD004352.
5. Nanda K. Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth. Cochrane Database Syst Rev 2002, (4). CD003933.
6. Gaudet L.M., Singh K., Weeks L., et al. Effectiveness of terbutaline pump for the prevention of preterm birth. A systematic review and meta-analysis. PLoS One 2012, 7:e31679.
7. Available at: Accessed January 21, 2014. http://www.fda.gov/drugs/drugsafety/ucm243539.htm.
8. Conde-Agudelo A., Romero R., Kusanovic J.P. Nifedipine in the management of preterm labor: a systematic review and metaanalysis. Am J Obstet Gynecol 2011, 204:134.e1-134.e20.
9. Roos C., Spaanderman M., Schuit E., et al. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes. JAMA 2013, 309:41-47.
10. Niebyl J.R., Blake D.A., White R.D., et al. The inhibition of preterm labor with indomethacin. Am J Obstet Gynecol 1980, 136:1014.
11. King J., Flenady V., Cole S., et al. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database Syst Rev 2005, (2). CD001992.
12. Mercer B.M., Merlino A.A., Society for Maternal Fetal Medicine Magnesium sulfate for preterm labor and preterm birth. Obstet Gynecol 2009, 114:650.
13. Rouse D.J., Hirtz D.G., Thom E., et al. Arandomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. NEngl J Med 2008, 359:895.
14. Papatsonis D., Flenady V., Cole S., et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005, (3). CD004452.
15. Conde-Agudelo A., Romer R. Transdermal nitroglycerin for the treatment of preterm labor: a systematic review and meta-analysis. Am J Obstet Gynecol 2013, 209:551.e1-551.e18.
16. Iams J.D., Berghella V. Care for women with prior preterm birth. Am J Obstet Gynecol 2010, 203:89-100.
17. Elliott J.P., Miller H.S., Coleman S., et al. Arandomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin. JPerinatol 2005, 25:626-630.
18. Sosa C., Althabe F., Belizan J., et al. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev 2004, (1). CD003581.
19. American College of Obstetricians and Gynecologists Management of preterm labor. Practice Bulletin No. 127. Obstet Gynecol 2012, 119:1308-1317.
20. Klebanoff M.A., Carey J.C., Hauth J.C., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. NEngl J Med 2001, 345:487-493.
21. Leitich H., Bodner-Adler B., Brunbauer M., et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003, 189:139-147.
22. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. NEngl J Med 2000, 342:534-540.
23. McDonald H.M., Brocklehurst P., Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy (Review). Cochrane Database Syst Rev 2007, (1). CD000262.
24. Brocklehurst P., Gordon A., Heatley E., et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013, (1). CD000262.
25. Okun N., Gronau K.A., Hannah M.E. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol 2005, 105:857-868.
26. Cotch M.F., Hillier S.L., Gibbs R.S., et al. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal infections and prematurity study group. Am J Obstet Gynecol 1998, 178:374-380.
27. Kiss H., Petricevic L., Hussiein P. Prospective randomized controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 2004, 329:371.
28. Folger A.T. Maternal Chlamydia trachomatis infections and preterm birth: The impact of early detection and eradication during pregnancy. Matern Child Health J 2014, 18:1795-1802.
29. Martin D.H., Eschenbach D.A., Cotch M.F., et al. Double-blind placebo-controlled treatment trial of Chlamydia trachomatis endocervical infections in pregnant women. Infect Dis Obstet Gynecol 1997, 5:10-17.
30. Johnson H.L., Ghanem K.G., Zenilman J.M., et al. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Transm Dis 2011, 38:167-171.
31. Mann J.R., McDermott S., Gill T. Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid. JMatern Fetal Neonatal Med 2010, 23:563-568.
32. Valkenburg-van den Berg A.W., Sprij A.J., Dekker F.W., et al. Association between colonization with Group B Streptococcus and preterm delivery: a systematic review. Acta Obstet Gynecol Scand 2009, 88:958-976.
33. Klebanoff M.A., Regan J.A., Rao A.V., et al. Outcome of the Vaginal infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol 1995, 172:1540-1545.
34. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep 2010, 59(RR-10):1-36.
35. Sheiner E., Mazor-Drey E., Levy A. Asymptomatic bacteriuria during pregnancy. JMatern Fetal Neonatal Med 2009, 22:423-427.
36. Smaill F., Vazquez J.C. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007, (2). CD000490.
37. Banhidy F., ACS N., Puho E.H., et al. Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments. Scand J Infect Dis 2007, 39:390-397.
38. Chen Y.K., Chen S.F., Li H.C., et al. No increased risk of adverse pregnancy outcomes in women with urinary tract infections: a nationwide population-based study. Acta Obstet Gynecol Scand 2010, 89:882-889.
39. Wing D.A., Fassett M.J., Getahun D. Acute pyelonephritis in pregnancy: an 18 year retrospective analysis. Am J Obstet Gynecol 2013.
40. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomized trial. Lancet 2001, 357:989-994.
41. Romero R., Sibai B., Caritis S., et al. Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded placebo-controlled trial. Am J Obstet Gynecol 1993, 169:764-774.
42. Offenbacher S., Katz V., Fertik G., et al. Periodontal infection as a possible risk factor for preterm low birth weight. JPeriodontol 1996, 67:1103-1113.
43. Jeffcoat M.D., Geurs N.C., Reddy M.S., et al. Periodontal infection and preterm birth: results of a prospective study. JAm Dent Assoc 2001, 132:875-880.
44. Polyzos N.P., Polyzos I.P., Zavos A., et al. Obstetric outcomes after treatment of periodontal disease during pregnancy: systematic review and meta-analysis. BMJ 2010, 341:c7017.
45. Chambrone L., Pannuti C.M., Guglielmetti M.R., et al. Evidence grade associating periodontitis with preterm birth and/or low birth weight: II: a systematic review of randomized trials evaluating the effects of periodontal treatment. JClin Periodontol 2011, 38:902-914.
46. Kim A.J., Lo A.J., Pullin D.A., et al. Scaling and root planing treatment for periodontitis to reduce preterm birth and low birth weight: a systematic review and meta-analysis of randomized controlled trials. JPeriodontol 2012, 83:1508-1519.
47. Arabin B., Halbesma J.R., Vork F., et al. Is treatment with vaginal pessaries an option in patients with a sonographically detected short cervix?. JPerinat Med 2003, 31:122.
48. Goya M., Pratcorona L., Merced C., et al. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012, 379(9828):1800-1806.
49. Liem S., Schuit E., Hegeman M., et al. Cervical pessary for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomized controlled trial. Lancet 2013, 382:1341-1349.
50. Multicenter randomized, controlled trial of a preterm birth prevention program. Am J Obstet Gynecol 1993, 169:352. Collaborative Group on Preterm Birth Prevention.
51. Whitworth M., Quenby S., Cockerill R.O., et al. Specialised antenatal clinics for women with a pregnancy at high risk of preterm birth (excluding multiple pregnancy) to improve maternal and infant outcomes. Cochrane Database Syst Rev 2011, (9). CD006760.
52. Orr S.T. Social support and pregnancy outcome: a review of the literature. Clin Obstet Gynecol 2004, 47:842.
53. Villar J., Farnot U., Barros F., et al. Arandomized trial of psychosocial support during high-risk pregnancies. The Latin American Network for Perinatal and Reproductive Research. NEngl J Med 1992, 327:1266.
54. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. NEngl J Med 2003, 348:2379-2385.
55. da Fonseca E.B., Bittar R.E., Carvalho M.H., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003, 188:419.
56. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30:687.
57. Dodd J.M., Jones L., Flenady V., et al. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013, (7). CD004947.
58. Combs C.A., Garite T., Maurel K., et al. 17-Hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2011, 204:221.e1-221.e8.
59. Rouse D.J., Caritis S.N., Peaceman A.M., et al. Atrial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. NEngl J Med 2007, 357:454-461.
60. Rode L., Klein K., Nicolaides K.H., et al. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011, 38:272-280.
61. Norman J.E., Mackenzie F., Owen P., et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomized, double-blind, placebo-controlled study and meta-analysis. Lancet 2009, 373:2034-2040.
62. Caritis S.N., Rouse D.J., Peaceman A.M., et al. Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial. Obstet Gynecol 2009, 113:285.
63. Fonseca E.B., Celik E., Parra M., et al. Progesterone and the risk of preterm birth among women with a short cervix. NEngl J Med 2007, 357:462-469.
64. Hassan S.S., Romero R., Vidyadhari D., PREGNANT Trial, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011, 38:18.
65. Grobman W.A., Thom E.A., Spong C.Y., et al. 17 Alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol 2012, 207:390.e1.
66. Romero R., Nicolaides K., Conde-Agudelo A., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review andmetaanalysis of individual patient data. Am J Obstet Gynecol 2012, 206:124.e1.
67. Iams J.D. Prevention of preterm parturition. NEngl J Med 2014, 370:1861.
68. Berghella V., Odibo A.O., Tolosa J.E. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: randomized controlled trial. Am J Obstet Gynecol 2004, 191:1311-1317.
69. Berghella V., Rafael T., Szychowski J.M., et al. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth. Obstet Gynecol 2001, 117:663-671.
70. Rust O.A., Atlas R.O., Reed J., et al. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 2001, 185:1098-1105.
71. Althuisius S.M., Dekker G.A., Hummel P., et al. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001, 185:1106-1112.
72. Owen J., Harnkins G., Iams J.D., et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009, 201:375.e1-375.e8.
73. To M.S., Alfirevix Z., Heath V.C., et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004, 363:1849-1853.
74. Rafael T.J., Mackeen A.D., Berghella V. The effect of 17-alpha-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage. Am J Perinatol 2011, 28:389-393.
75. Gyamfi-Bannerman C. The scope of the problem: the epidemiology of late preterm and early-term births. Semin Perinatol 2011, 35:246-248.
76. Spong B.Y., Mercer B.M., D'alton M., et al. Timing of indicated late-preterm and early-term birth. Obstet Gynecol 2011, 188:323-333.